The US government has said that it will not join a global effort to develop, manufacture and distribute a coronavirus vaccine, which is led by the World Health Organization.
As per reports, more than 170 countries are gearing up to participate in the Covid-19 Vaccines Global Access (Covax) Facility. The facility aims to speed-up vaccine development and ensure its distribution to all countries, especially to the most high-risk areas.
The plan is co-led by the WHO, the Coalition for Epidemic Preparedness Innovations and Gavi, the vaccine alliance. But the United States will not take part in the initiative because the White House does not want to work with the WHO. US President Donald Trump has repeatedly criticised the World Health Organization’s “China-centric” response to the coronavirus pandemic.
Judd Deere, a spokesperson for the White House said, “The United States will continue to engage our international partners to ensure we defeat this virus, but we will not be constrained by multilateral organizations influenced by the corrupt World Health Organization and China.”
As per experts, this move by the US will impact what happens elsewhere in terms of vaccine development. Covax aims to discourage stockpiling of the COVID-19 vaccine and distributing it to the high-risk people in every country first. Experts believe that this strategy could lead to better health outcomes at lower costs.